BLEVF logo

Beleave Inc. (BLEVF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Beleave Inc. (BLEVF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 44/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 18 Mar 2026
44/100 AI Puanı

Beleave Inc. (BLEVF) Sağlık ve Boru Hattı Genel Bakışı

CEOVasilios Panagiotakopoulos
MerkezOakville, CA
Halka Arz Yılı2016
SektörHealthcare

Beleave Inc., based in Canada, cultivates and sells medical and recreational cannabis, operating Medi-Green clinics in Ontario and Quebec. With a negative profit margin of -1423.0% and trading on the OTC market, the company navigates a competitive landscape against peers like ACGJ and ARTH.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 18 Mar 2026

Yatırım Tezi

Investing in Beleave Inc. (BLEVF) presents a speculative opportunity within the Canadian cannabis market. Key value drivers include the potential expansion of its Medi-Green clinic network and increased sales of recreational cannabis products. However, the company's negative profit margin of -1423.0% raises concerns about its financial sustainability. Growth catalysts include potential regulatory changes that could expand market access and increased consumer demand for cannabis products. The company's high beta of -148.45 indicates extreme volatility relative to the market. The investment thesis hinges on Beleave's ability to improve its operational efficiency, reduce costs, and achieve profitability in a highly competitive environment. Investors should carefully consider the risks associated with investing in a company with a history of financial losses and significant market volatility.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Negative Profit Margin: Beleave Inc. has a profit margin of -1423.0%, indicating significant losses relative to revenue.
  • Gross Margin: The company's gross margin is 34.4%, suggesting some efficiency in production costs before accounting for operating expenses.
  • Market Cap: Beleave Inc.'s market capitalization is $0.00B, reflecting its small size and potential risks.
  • P/E Ratio: The company's P/E ratio is -0.00, which is not meaningful due to negative earnings.
  • Beta: Beleave Inc. has a beta of -148.45, indicating extreme volatility and a negative correlation with the market.

Rakipler & Benzerleri

Güçlü Yönler

  • Established network of medical cannabis clinics.
  • Integrated business model.
  • Brand recognition in the Canadian market.

Zayıflıklar

  • Negative profit margin.
  • High beta indicating extreme volatility.
  • Small market capitalization.

Katalizörler

  • Upcoming: Potential regulatory changes that could expand market access for cannabis products.
  • Ongoing: Increasing consumer demand for cannabis products.
  • Ongoing: Expansion of the Medi-Green clinic network.

Riskler

  • Ongoing: Intense competition in the Canadian cannabis market.
  • Potential: Fluctuations in cannabis prices.
  • Potential: Evolving regulations.
  • Ongoing: Negative profit margin and financial losses.
  • Ongoing: Low liquidity due to OTC market trading.

Büyüme Fırsatları

  • Expansion of Medi-Green Clinic Network: Beleave Inc. can expand its network of Medi-Green medical cannabis clinics in Ontario and Quebec. The market for medical cannabis is growing, driven by increasing awareness of its therapeutic benefits and the aging population. Expanding the clinic network would provide Beleave with a direct channel to patients, allowing it to offer personalized care and build brand loyalty. The timeline for expansion depends on regulatory approvals and capital availability, but represents a significant growth opportunity in the coming years.
  • Increased Sales of Recreational Cannabis Products: Beleave Inc. can increase its sales of recreational cannabis products through its retail stores and online platform. The recreational cannabis market is larger than the medical cannabis market, offering significant growth potential. To capitalize on this opportunity, Beleave needs to develop innovative products, enhance its marketing efforts, and expand its distribution network. The timeline for achieving significant growth in recreational cannabis sales is dependent on market trends and competitive dynamics.
  • Development of New Cannabis Products: Beleave Inc. can develop new cannabis products to meet evolving consumer preferences. The market for cannabis products is constantly evolving, with new products and consumption methods emerging regularly. By investing in research and development, Beleave can create innovative products that appeal to a wider range of consumers. The timeline for developing and launching new products depends on regulatory approvals and market demand, but represents a long-term growth opportunity.
  • Strategic Partnerships and Acquisitions: Beleave Inc. can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. The cannabis industry is consolidating, with larger companies acquiring smaller players to gain access to new markets and technologies. By partnering with other companies or acquiring complementary businesses, Beleave can accelerate its growth and enhance its competitive position. The timeline for pursuing strategic partnerships and acquisitions depends on market conditions and available opportunities.
  • International Expansion: Beleave Inc. can explore opportunities for international expansion, particularly in countries where cannabis is legal or becoming legal. The global cannabis market is growing rapidly, offering significant growth potential for companies that can successfully navigate international regulations and market dynamics. Expanding into new markets would diversify Beleave's revenue streams and reduce its reliance on the Canadian market. The timeline for international expansion depends on regulatory changes and market opportunities in other countries.

Fırsatlar

  • Expansion of clinic network.
  • Increased sales of recreational cannabis products.
  • Development of new cannabis products.

Tehditler

  • Intense competition in the Canadian cannabis market.
  • Evolving regulations.
  • Fluctuations in cannabis prices.

Rekabet Avantajları

  • Established network of Medi-Green medical cannabis clinics.
  • Integrated business model encompassing cultivation, retail, and clinic operations.
  • Brand recognition in the Canadian cannabis market.

BLEVF Hakkında

Beleave Inc. was founded to participate in the burgeoning Canadian cannabis market, focusing on both medical and recreational applications. The company cultivates cannabis and manufactures related products, selling them through its own retail stores and online platforms. Additionally, Beleave operates a network of medical cannabis clinics under the Medi-Green banner in Ontario and Quebec, providing patient access and education. The company's business model integrates cultivation, product development, retail, and clinic operations to serve a broad spectrum of cannabis consumers and patients. Beleave Inc. is headquartered in Oakville, Canada, and has sought to establish a presence across the Canadian market. However, the company faces challenges in achieving profitability, as reflected in its significant negative profit margin. Beleave competes with other cannabis producers and retailers, striving to differentiate itself through product quality, clinic services, and brand recognition. The company's strategy involves expanding its product offerings and clinic network to capture a larger share of the Canadian cannabis market. Beleave aims to capitalize on the growing acceptance and legalization of cannabis in Canada, while navigating regulatory complexities and competitive pressures.

Ne Yaparlar

  • Cultivates medical and recreational cannabis.
  • Sells cannabis products through retail stores.
  • Operates an online platform for cannabis sales.
  • Manages a network of medical cannabis clinics under the Medi-Green banner.
  • Provides patient access and education through its clinics.
  • Manufactures cannabis-related products.

İş Modeli

  • Cultivating cannabis and processing it into various products.
  • Selling cannabis products directly to consumers through retail stores and online.
  • Generating revenue from patient consultations and cannabis prescriptions through Medi-Green clinics.

Sektör Bağlamı

Beleave Inc. operates within the Canadian cannabis industry, which has experienced rapid growth and increasing competition since legalization. The market is characterized by evolving regulations, shifting consumer preferences, and the emergence of numerous players vying for market share. Companies like Beleave face the challenge of differentiating themselves in a crowded market while navigating complex regulatory frameworks. The industry is also subject to fluctuations in cannabis prices and changing consumer demand patterns. Beleave competes with larger, more established cannabis companies, as well as smaller, niche players. The company's success depends on its ability to innovate, execute its business strategy effectively, and adapt to the dynamic market environment.

Kilit Müşteriler

  • Medical cannabis patients seeking therapeutic relief.
  • Recreational cannabis consumers.
  • Individuals seeking cannabis-related information and education.
AI Güveni: 69% Güncellendi: 18 Mar 2026

Finansallar

Grafik & Bilgi

Beleave Inc. (BLEVF) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

BLEVF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

BLEVF için Wall Street fiyat hedefi analizi.

MoonshotScore

44/100

Bu puan ne anlama geliyor?

MoonshotScore, BLEVF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Vasilios Panagiotakopoulos

CEO

Vasilios Panagiotakopoulos serves as the CEO of Beleave Inc. His background and experience prior to joining Beleave are not detailed in the provided data. As CEO, he is responsible for overseeing the company's operations, strategic direction, and financial performance. His leadership is crucial for navigating the competitive Canadian cannabis market and achieving the company's growth objectives.

Sicil: Due to limitations in the provided data, it is not possible to assess Vasilios Panagiotakopoulos's specific achievements or strategic decisions as CEO of Beleave Inc. His track record and the company's milestones under his leadership are currently unknown.

BLEVF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Beleave Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may be subject to greater risks due to less stringent listing requirements. Investing in companies on the OTC Other tier requires careful due diligence and a thorough understanding of the associated risks, as these companies may not be subject to the same regulatory oversight as those listed on major exchanges.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC stock, BLEVF likely suffers from low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares quickly at desired prices. The illiquidity can exacerbate price volatility and increase transaction costs. Investors should be aware of the potential challenges in executing trades and the risk of significant price fluctuations due to limited trading activity.
OTC Risk Faktörleri:
  • Limited financial disclosure due to OTC Other tier status.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or mismanagement compared to listed companies.
  • Limited regulatory oversight.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal standing.
  • Obtain and review available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the company's capital structure and ownership.
  • Assess the liquidity and trading volume of the stock.
  • Consult with a qualified financial advisor.
Meşruiyet Sinyalleri:
  • Operation of Medi-Green medical cannabis clinics.
  • Cultivation and sale of cannabis products.
  • Presence in the Canadian cannabis market.

Yatırımcılar Beleave Inc. (BLEVF) Hakkında Ne Soruyor

BLEVF için değerlendirilmesi gereken temel faktörler nelerdir?

Beleave Inc. (BLEVF) şu anda yapay zeka skoru 44/100, düşük puanı gösteriyor. Temel güçlü yan: Established network of medical cannabis clinics.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the Canadian cannabis market.. Bu bir finansal tavsiye değildir.

BLEVF MoonshotScore'u nedir?

BLEVF şu anda MoonshotScore'da 44/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

BLEVF verileri ne sıklıkla güncellenir?

BLEVF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler BLEVF hakkında ne diyor?

BLEVF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

BLEVF'a yatırım yapmanın riskleri nelerdir?

BLEVF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the Canadian cannabis market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

BLEVF'ın P/E oranı nedir?

BLEVF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için BLEVF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

BLEVF aşırı değerli mi, yoksa düşük değerli mi?

Beleave Inc. (BLEVF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

BLEVF'ın temettü verimi nedir?

Beleave Inc. (BLEVF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited financial information available for Beleave Inc.
  • Lack of analyst coverage for BLEVF stock.
  • OTC listing indicates higher risk and lower liquidity.
Veri Kaynakları

Popüler Hisseler